Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial

PURPOSE: The long-term update of US GI Intergroup RTOG 98-11 anal cancer trial found that concurrent chemoradiation (CCRT) with fluorouracil (5-FU) plus mitomycin had a significant impact on disease-free survival (DFS) and overall survival (OS) compared with induction plus concurrent 5-FU plus cispl...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Gunderson, Leonard L., Moughan, Jennifer, Ajani, Jaffer A., Pedersen, John E., Winter, Kathryn A., Benson, Al B., Thomas, Charles R., Mayer, Robert J., Haddock, Michael G., Rich, Tyvin A., Willett, Christopher G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938865/
https://ncbi.nlm.nih.gov/pubmed/24035327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2013.07.035
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk